Health & Environmental Research Online (HERO)


Print Feedback Export to File
8442105 
Journal Article 
Pharmacological treatments of COVID-19 
Sahebnasagh, A; Avan, R; Saghafi, F; Mojtahedzadeh, M; Sadremomtaz, A; Arasteh, O; Tanzifi, A; Faramarzi, F; Negarandeh, R; Safdari, M; Khataminia, M; Rezai Ghaleno, H; Habtemariam, S; Khoshi, A; , 
2020 
1 
Pharmacological Reports
ISSN: 1734-1140
EISSN: 2299-5684 
72 
6 
1446-1478 
English 
32816200 
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also its related symptoms to SARS-CoV1. The ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact is considered by the WHO as a global public health emergency. Since there is no specific treatment available for SARS-CoV2 infection, and or COVID-19, several clinical and sub-clinical studies are currently undertaken to find a gold-standard therapeutic regimen with high efficacy and low side effect. Based on the published scientific evidence published to date, we summarized herein the effects of different potential therapies and up-to-date clinical trials. The review is intended to help readers aware of potentially effective COVID-19 treatment and provide useful references for future studies. 
Index Medicus; COVID-19; SARS-CoV2; Pneumonia; Pharmacology; Animals; Clinical Trials as Topic; COVID-19 -- virology; SARS-CoV-2 -- isolation & purification; COVID-19 -- drug therapy